Thrombectomy Devices

Thrombectomy Devices

Global Thrombectomy Devices Market to Reach US$2.2 Billion by 2030

The global market for Thrombectomy Devices estimated at US$1.5 Billion in the year 2023, is expected to reach US$2.2 Billion by 2030, growing at a CAGR of 5.2% over the analysis period 2023-2030. Mechanical Thrombectomy, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Rheolytic Thrombectomy segment is estimated at 5.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$403.6 Million While China is Forecast to Grow at 8.9% CAGR

The Thrombectomy Devices market in the U.S. is estimated at US$403.6 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$501.0 Million by the year 2030 trailing a CAGR of 8.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.0% and 5.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.3% CAGR.

Global Thrombectomy Devices Market - Key Trends and Drivers Summarized

Why Are Thrombectomy Devices Transforming Stroke and Vascular Treatment?

Thrombectomy devices have revolutionized the treatment of stroke and other vascular conditions by providing minimally invasive solutions for removing blood clots from arteries and veins. These devices are used to treat patients experiencing ischemic strokes, pulmonary embolisms, and deep vein thrombosis (DVT), significantly reducing the risk of long-term disability or death. Mechanical thrombectomy, in particular, has emerged as a standard of care for acute ischemic stroke, offering a life-saving option that can restore blood flow to the brain when administered quickly. As the prevalence of cardiovascular and neurovascular diseases rises, the demand for thrombectomy devices continues to grow, driven by an aging population and increasing awareness of stroke treatment options.

How Is the Thrombectomy Devices Market Segmented?

The main types of thrombectomy devices are mechanical, rheolytic and aspiration devices. Mechanical thrombectomy devices are widely used in stroke treatment, while aspiration thrombectomy devices are commonly used for peripheral artery disease (PAD) and venous thromboembolism (VTE). Applications include the treatment of neurovascular diseases, cardiovascular conditions, and peripheral vascular diseases. End-users of thrombectomy devices include hospitals, specialty clinics, and ambulatory surgical centers. Hospitals remain the largest end-user segment, but the use of these devices in outpatient settings is expanding as technology improves and more minimally invasive procedures are performed outside of traditional hospital environments.

What Are the Key Technological Advancements in Thrombectomy Devices?

Technological innovations are playing a critical role in advancing thrombectomy device performance and patient outcomes. New generation devices feature improved catheter designs that allow for more precise navigation through complex vascular structures, reducing procedure times and improving clot removal efficiency. Advanced aspiration systems are being developed to enhance the ability to remove large clots without damaging surrounding tissues. Additionally, the integration of real-time imaging technologies, such as fluoroscopy and ultrasound guidance, is improving the accuracy and safety of thrombectomy procedures. Research into next-generation bioresorbable thrombectomy devices is also underway, which could offer even less invasive options for patients, reducing the need for follow-up surgeries.

What Factors Are Driving Growth in the Thrombectomy Devices Market?

The growth in the thrombectomy devices market is driven by several factors, including the rising prevalence of cardiovascular and neurovascular diseases, the increasing adoption of minimally invasive surgical procedures, and advancements in thrombectomy technology. The aging population is a significant driver, as older individuals are more prone to conditions like stroke and deep vein thrombosis. Additionally, growing awareness of stroke symptoms and the importance of rapid intervention is boosting demand for thrombectomy devices. The expansion of healthcare infrastructure in emerging markets and the increased use of thrombectomy devices in ambulatory surgical centers are further contributing to market growth. Technological innovations, particularly in mechanical and aspiration devices, are enhancing the effectiveness and safety of thrombectomy procedures, fueling market demand.

Select Competitors (Total 13 Featured) -

• ACANDIS GmbH
• Argon Medical Devices, Inc.
• Boston Scientific Corporation
• BTG International Ltd.
• Edwards Lifesciences Corporation
• Johnson & Johnson
• Medtronic PLC
• Penumbra, Inc.
• Phenox GmbH
• Spectranetics Corporation
• Straub Medical AG
• Stryker Corporation
• Teleflex Inc.
• Terumo Corporation

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.